1 |
Arret B, Johnson DP, Kirshbaum A. Outline of details for microbiological assays of antibiotics: second revision. J Pharm Sci 1971, 60, 1689-1694
DOI
|
2 |
Dardi MS, Sharma SK, Srivastava AK. Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves. Vet Res Commun 2004, 28, 331-338
|
3 |
Hancock RE, Bellido F. Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins. J Antimicrob Chemother 1992, 29 (Suppl A), 1-6
DOI
|
4 |
Isert D, Klesel N, Limbert M, Markus A, Seibert G, Schrinner E. Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs. J Antimicrob Chemother 1992, 29 (Suppl A), 31-37
DOI
|
5 |
Muller M, Rohde B, Kovar A, Georgopoulos A, Eichler HG, Derendorf H. Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis. J Clin Pharmacol 1997, 37, 1108-1113
DOI
ScienceOn
|
6 |
Rule R, Quiroga GH, Rubio M, Buschiazzo HO, Buschiazzo PM. The pharmacokinetics of ceftazidime in lactating and non-lactating cows. Vet Res Commun 1996, 20, 543-550
DOI
|
7 |
Sauermann R, Delle-Karth G, Marsik C, Steiner I, Zeitlinger M, Mayer-Helm BX, Georgopoulos A, Muller M, Joukhadar C. Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients. Antimicrob Agents Chemother 2005, 49, 650-655
DOI
ScienceOn
|
8 |
Wisemann LR, Lamb HM. Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia. Drugs 1997, 54, 117-140
DOI
ScienceOn
|
9 |
Klesel N, Seeger K. Pharmacokinetic properties of the new cephalosporin antibiotic HR 810 in animals. Infection 1983, 11, 318-321
|
10 |
Jafari HS, Saez-Llorens X, Ramilo O, Shelton SL, McCracken GH Jr. Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis. Antimicrob Agents Chemother 1991, 35, 220-223
DOI
ScienceOn
|
11 |
Paradis D, Vallee F, Allard S, Bisson C, Daviau N, Drapeau C, Auger F, LeBel M. Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem and ciprofloxacin. Antimicrob Agents Chemother 1992, 36, 2085-2092
DOI
ScienceOn
|
12 |
Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. pp. 433- 444, Marcel Dekker, New York, 1982
|
13 |
Kita Y, Yamaaki T, Imada A. Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals. Antimicrob Agents Chemother 1992, 36, 2481-2486
DOI
ScienceOn
|
14 |
Nakanomyo H, Esumi Y, Takaichi M, Seki H, Ninomiya S, Okamura Y, Sudo Y. Study on the pharmacokinetics of cefepime (II). Jap J Antibiot 1992, 45, 938-942
|
15 |
Bertram MA, Bruckner DA, Young LS. In vitro activity of HR 810, a new cephalosporin. Antimicrob Agents Chemother 1984, 26, 277-279
DOI
ScienceOn
|
16 |
Kavi J, Ashby JP, Wise R, Donovan IA. Intraperitoneal penetration of cefpirome. Eur J Clin Microbiol Infect Dis 1989, 8, 556-558
DOI
|
17 |
Sharma SK, Srivastava AK. Cefotaxime pharmacokinetics in male buffalo calves following multiple dosing. Vet Arh 2003, 73, 191-197
|
18 |
Mrestani Y, Bretschneider B, Hartl A, Neubert RHH. Invitro and in-vivo studies of cefpirom using bile salts as absorption enhancers. J Pharm Pharmacol 2003, 55, 1601- 1606
DOI
ScienceOn
|
19 |
Arai S, Kobayashi S, Hayashi S, Sakaguchi T. Distribution of cefpirome (HR 810) to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch. Antimicrob Agents Chemother 1988, 32, 1396-1399
DOI
ScienceOn
|
20 |
Gardner SY, Papich MG. Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs. J Vet Pharmacol Ther 2001, 24, 187-192
DOI
ScienceOn
|